ITGAX and melanoma: In both B16 melanoma–bearing and LLC tumor–bearing mice, not only were the percentages of CD11c+ cells in the blood increased, but expression of PD-L1, CSF1R, and PDH in CD11c+ cells was also upregulated (Figure 7, A–D).